Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives

Contraception

Volumn 74, Issue 3, 2006, Pages 220-223

  Sabatini, Rosa ^a   Cagiano, Raffaele ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Discontinuation; Oral contraceptives; Sexual desire; Sexual satisfaction; Side effects; Vaginal ring

Indexed keywords

CONTRACEPTIVE AGENT; ETHINYLESTRADIOL; ETONOGESTREL; GESTODENE; LEVONORGESTREL;

ADULT; ARTICLE; BREAST TENDERNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG USE; FEMALE; HORMONAL CONTRACEPTION; HUMAN; INCIDENCE; IRRITABILITY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; NAUSEA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SEXUAL SATISFACTION; SIDE EFFECT; SPOTTING; VAGINA RING; VAGINAL DRYNESS; WEIGHT GAIN; WELLBEING;

ADMINISTRATION, INTRAVAGINAL; ADULT; AFFECT; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL; DESOGESTREL; ETHINYL ESTRADIOL; FEMALE; HUMANS; LEVONORGESTREL; LIBIDO; MENSTRUAL CYCLE; NORPREGNENES; PROSPECTIVE STUDIES; REPRODUCTION; UTERINE HEMORRHAGE;

EID: 33746821075     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.03.022     Document Type: Article

References (13)

1. Piccinino L.J., and Mosher W.D. Trends in contraceptive use in the United States: 1982-1995. Fam Plann Perspect 30 (1998) 4-10
2. Rosenberg M.J., Meyers A., and Roy V. Efficacy, cycle control and side effects of low and lower dose oral contraceptives: a randomized trial of 20 μg and 35 μg estrogen preparations. Contraception 60 (2000) 321-329
3. Archer D.F., Maheux R., Del Conte, O'Brien F.B., and North American Levonorgestrel Study Group (NALSG). Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinylestradiol (Alesse). Am J Obstet Gynecol 181 (1999) S39-S44
4. Bjarnadottir R.I., Tuppurainem M., and Killik S.R. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinylestradiol. Am J Obstet Gynecol 186 (2002) 389-395
5. Sabatini R. NuvaRing and sexual comfort Giorn. Ital Ostet Ginecol 26 (2004) 321-324
6. Sanders S.A., Graham C.A., Bass J.L., and Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 64 (2001) 51-58
7. Dei M., Verni A., Bigozzi L., and Bruni V. Sex steroids and libido. Eur J Contracept Reprod Health Care 2 (1997) 253-258
8. Boerrigter P.J., Hellman H., and Dolker M. International clinical experience with a new low-dose monophasic oral contraceptive containing levonorgestrel 100 μg and ethinylestradiol 20 μg. Clin Ther 21 (1999) 118-127
9. Coney P.J., Washenik K., Langley R.G.B., Di Giovanna J.J., and Harrison D.D. Weight change and adverse events incidence with a low-dose oral contraceptive: two randomized, placebo controlled trials. Contraception 63 (2001) 297-302
10. Caruso S., Agnello C., Intelisano G., Farina M., Di Mari L., and Cianci A. Sexual behavior of women taking low-dose oral contraceptive containing 15 μg ethinylestradiol/60 μg gestodene. Contraception 69 (2004) 234-237
11. Belsey E.M., Machin D., and D'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. Contraception 34 (1986) 253-260
12. Chavez A., and Del Conte A. Comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 μg/20 μg versus triphasic norethindrone/ethinylestradiol 500-750-1000 μg/35 μg, a multicenter randomized open-label study. Eur J Contracept Reprod Health Care 4 (1999) 75-83
13. Winkler U.H., Ferguson H., and Mulders J.A.P.A. Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 μg ethinylestradiol. Contraception 69 (2004) 469-476